技术指标
指标
数值
方向
MACD(12,26,9)
-4.784
中性
RSI(14)
40.200
中性
STOCH(KDJ)(9,3,3)
4.390
超卖
ATR(14)
4.221
低波动
CCI(14)
-108.949
卖出
Williams %R
97.460
超卖
TRIX(12,20)
0.277
卖出
StochRSI(14)
0.000
超卖
搜索
Moderna Inc
MRNA添加自选
57.200USD
+0.180+0.32%
收盘 07-23 16:00（美东）报价延迟15分钟
22.54B总市值
亏损市盈率 TTM
关键数据
57.200今开
58.430最高
6.28K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.00%换手率
57.020昨收
56.275最低
137.59K成交额
亏损市盈率静
2.61市净率
0.00%股息率 TTM
-26.41%ROA
59.55052周最高
-0.01量比
-3.56B净利润
394.00M总股本
-8.1390每股收益TTM
1.06Beta
-36.56%ROE
22.28052周最低
3.78%振幅
-135.73%毛利率
22.54B总市值
-1.44回报/风险
3.90%风险率
TradingKey Moderna Inc股票评分
单位: USD 更新时间: 2026-07-23操作建议
Moderna Inc当前公司基本面数据相对健康，增长潜力较大。当前估值合理，在药品行业排名68/155位。机构持股占比非常高，近一月多位分析师给出公司评级为持有。最高目标价53.28。中期看，股价处于上升通道。近一个月，市场表现一般，但基本面评分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Moderna Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
31°C
过冷
过热
看空
Moderna Inc亮点
亮点风险
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).
分析师目标
根据
24
位分析师
持有
评级
53.275
目标均价
-10.70%
涨幅空间
Moderna Inc新闻
收益预测
分析师评级
根据
24
位分析师
持有
评级
53.275
目标均价
-10.70%
涨幅空间
强力买入
买入
持有
卖出
强力卖出
同行比较
160
总数
6
中位数
9
平均值
公司名称
评级分布
分析师数
Moderna Inc
MRNA
24
Biogen Inc
BIIB
38
安进
AMGN
37
礼来
LLY
34
艾伯维
ABBV
33
辉瑞
PFE
32
1
2
3
...
32
技术指标
移动平均线
指标
数值
方向
MA5
59.212
卖出
MA10
63.021
卖出
MA20
68.057
卖出
MA50
57.682
卖出
MA100
54.634
买入
MA200
44.012
买入
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Moderna Inc简介
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. The Company’s diverse development pipeline consists of 44 therapeutic and vaccine programs, 11 of which are in late-stage development. Its commercial products include Spikevax (its COVID vaccine) and mRESVIA (its respiratory syncytial virus (RSV) vaccine). Additionally, it has achieved four positive Phase III data readouts for its COVID vaccine (mRNA-1283), its RSV vaccine for high-risk adults aged 18 to 59 (mRNA-1345), its seasonal flu+COVID vaccine (mRNA-1083), and its seasonal flu vaccine (mRNA-1010).
公司代码MRNA
公司Moderna Inc
CEOBancel (Stephane)
网址https://www.modernatx.com/
公司股东
相关品种
热门品种
常见问题
Moderna Inc(MRNA)的当前股价是多少？
Moderna Inc(MRNA)的当前股价是 57.01。
Moderna Inc的股票代码是什么？
Moderna Inc的股票代码是MRNA。
Moderna Inc股票的52周最高点是多少？
Moderna Inc股票的52周最高点是59.55。
Moderna Inc股票的52周最低点是多少？
Moderna Inc股票的52周最低点是22.28。
Moderna Inc的市值是多少？
Moderna Inc的市值是22.46B。
现在Moderna Inc(MRNA)的股票是买入、持有还是卖出？
根据分析师评级，Moderna Inc(MRNA)的总体评级为signal_hold，目标价格为53.28。
Moderna Inc(MRNA)股票的每股收益（EPS TTM）是多少
Moderna Inc(MRNA)股票的每股收益（EPS TTM）是-7.25。